Scott Steward-Tharp DDS, PhDClinical Assistant Professor (adjunct), Pathology & Laboratory Medicine, Temple University Hospital, Lewis Katz School of Medicine, Philadelphia, PA; Postdoctoral Research Fellow, Pathology, University of Iowa, Iowa City, IA
Dr. Scott Steward-Tharp is a board-certified oral and maxillofacial pathologist with research interests exploring lymphocyte functions within the pathogenesis and regulation of autoimmune diseases and cancer. Dr. Steward-Tharp sees clinic patients for the diagnosis, management, and treatment of numerous diseases affecting oral and perioral tissues. Additionally, he provides microscopic interpretation and diagnosis of oral tissue specimens submitted by contributors from across the US.
Dr. Steward-Tharp has authored and coauthored a number of research articles and serves as a reviewer for both dental and medical journals. He has received several awards for his accomplishments, including training fellowships through both the Howard Hughes Medical Institute and the National Institutes of Health. He is a fellow of the American Academy of Oral and Maxillofacial Pathology, a member of the Omicron Kappa Upsilon National Dental Honor Society, the American Dental Association, and the United States and Canadian Academy of Pathology, among other professional organizations.
Dr. Steward Tharp received his DDS from the University of Iowa College of Dentistry and Dental Clinics, where he underwent residency training in oral and maxillofacial pathology. He was awarded a DPhil/PhD in pathology from the University of Oxford (UK).
Recent Contributions to PracticeUpdate:
- Higher Platelet-to-Lymphocyte Ratio Is a Poor Prognostic Predictor for Oral Cancer
- Gingival Overgrowth Induced by Anticonvulsant Drugs
- Tacrolimus 0.03% Ointment Demonstrates Good Short-Term Efficacy and Safety for the Treatment of Exfoliative Cheilitis
- Association Between Serum Zinc Levels and Recurrent Aphthous Stomatitis
- HPV Genotype Distribution in Head and Neck Cancer: Informing Strategies for Cancer Prevention, Diagnosis, and Management
- Race and Gender Interact to Influence Overall Survival in Head and Neck Squamous Cell Carcinoma
- Survival and Relapse Rates for Oral SCC Remain Stable Despite Diagnostic and Therapeutic Improvements Over 4 Decades
- Oral Microbiome and Onset of Oral Mucositis in SCCHN
- 2020 Top Stories in Clinical Dentistry: Lichen Planus and Squamous Cell Carcinoma: The Present State of Association Data to Address Your Patient’s Questions
- The Dentist's Approach to Potentially Premalignant Oral Lesions